For Esophageal Repair

An extracellular matrix hydrogel that can prevent stricture following mucosal resection in the esophagus

Naturally occurring, biologic sheet materials composed of extracellular matrix (ECM) have been successfully used for almost 20 years as surgical meshes and topical powders.

Aims to reduce the number of dilation events and frequency of patient follow up visits due to stricture complications after endoscopic eradication therapy by promoting constructive epithelial remodeling via noninvasive delivery, allowing surgeons to more aggressively remove lesions in the upper GI tract.


> 2 million

Upper GI endoscopic resection procedures performed in the US in 2018


Patients will develop stricture after > 75% circumferential mucosal resection of long segments


Average number of follow up visits for complete endoscopic eradication per patient

ECM Therapeutics, Inc. is a regenerative medicine company that develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM).

About Us